AAAAAA
Results:
1-21
|
Results: 21
Authors:
Parsian, A
Perlmutter, JS
Citation: A. Parsian et Js. Perlmutter, Point mutations in the alpha-synuclein gene, METH MOL M, 62, 2001, pp. 3-11
Authors:
Matsumine, H
Hattori, N
Mizuno, Y
Citation: H. Matsumine et al., Autosomal recessive juvenile parkinsonism (AR-JP): Genetic diagnosis, METH MOL M, 62, 2001, pp. 13-29
Authors:
Goedert, M
Jakes, R
Crowther, RA
Spillantini, MG
Citation: M. Goedert et al., Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy as alpha-synucleinopathies, METH MOL M, 62, 2001, pp. 33-59
Authors:
Jensen, PH
Citation: Ph. Jensen, alpha-synuclein/amyloid interactions, METH MOL M, 62, 2001, pp. 61-65
Authors:
Jensen, PH
Citation: Ph. Jensen, Functional defect conferred by the Parkinson's disease-causing alpha-synuclein (Ala30Pro) mutation, METH MOL M, 62, 2001, pp. 67-72
Authors:
Ziv, I
Shirvan, A
Offen, D
Barzilai, A
Melamed, E
Citation: I. Ziv et al., Molecular biology of dopamine-induced apoptosis - Possible implications for Parkinson's disease, METH MOL M, 62, 2001, pp. 73-87
Authors:
Oo, TF
Burke, RE
Citation: Tf. Oo et Re. Burke, Animal models of induced apoptotic death in the substantia nigra, METH MOL M, 62, 2001, pp. 89-99
Authors:
Oo, TF
Burke, RE
Citation: Tf. Oo et Re. Burke, Apoptotic morphology in phenotypically defined dopaminergic neurons of thesubstantia nigra, METH MOL M, 62, 2001, pp. 101-112
Authors:
Przedborski, S
Dawson, TM
Citation: S. Przedborski et Tm. Dawson, The role of nitric oxide in Parkinson's disease, METH MOL M, 62, 2001, pp. 113-136
Authors:
Youdim, MBH
Drigues, N
Mandel, S
Citation: Mbh. Youdim et al., Oxidative stress indices in Parkinson's disease - Biochemical determination, METH MOL M, 62, 2001, pp. 137-153
Authors:
Ichinose, H
Ohye, T
Suzuki, T
Inagaki, H
Nagatsu, T
Citation: H. Ichinose et al., Quantification of tyrosine hydroxylase mRNA, METH MOL M, 62, 2001, pp. 157-166
Authors:
Miller, GW
Levey, AI
Citation: Gw. Miller et Ai. Levey, Immunochemical analysis of dopamine transporters in Parkinson's disease, METH MOL M, 62, 2001, pp. 167-177
Authors:
Miller, GW
Wang, YM
Gainetdinov, RR
Caron, MG
Citation: Gw. Miller et al., Dopamine transporter and vesicular monoamine transporter knockout mice - Implications for Parkinson's disease, METH MOL M, 62, 2001, pp. 179-190
Authors:
Lee, SH
Mouradian, MM
Citation: Sh. Lee et Mm. Mouradian, Transcription mechanisms for dopamine receptor genes, METH MOL M, 62, 2001, pp. 191-215
Authors:
Lee, SH
Mouradian, MM
Citation: Sh. Lee et Mm. Mouradian, Detection of DNA/protein interactions in dopamine receptor genes, METH MOL M, 62, 2001, pp. 217-227
Authors:
Lammers, CH
Hara, Y
Mouradian, MM
Citation: Ch. Lammers et al., In situ hybridization on brain tissue, METH MOL M, 62, 2001, pp. 229-246
Authors:
Oh, JD
Citation: Jd. Oh, Regulation of striatal N-methyl-D-aspartate receptor (NMDAR) function by phosphorylation of its subunits in Parkinsonian rats, METH MOL M, 62, 2001, pp. 247-253
Authors:
Grondin, R
Zhang, ZM
Elsberry, DD
Gerhardt, GA
Gash, DM
Citation: R. Grondin et al., Chronic intracerebral delivery of trophic factors via a programmable pump as a treatment for Parkinsonism, METH MOL M, 62, 2001, pp. 257-267
Authors:
Bankiewicz, KS
Pivirotto, P
Sanchez-Pernaute, R
Major, EO
Citation: Ks. Bankiewicz et al., Grafting genetically engineered cells into the striatum of nonhuman primates, METH MOL M, 62, 2001, pp. 269-278
Authors:
Tseng, JL
Aebischer, P
Citation: Jl. Tseng et P. Aebischer, Encapsulated cell implants as a novel treatment for Parkinson's disease, METH MOL M, 62, 2001, pp. 279-288
Authors:
Armstrong, RJE
Rosser, AE
Dunnett, SB
Barker, RA
Citation: Rje. Armstrong et al., Neural stem cell technology as a novel treatment for Parkinson's disease, METH MOL M, 62, 2001, pp. 289-307
Risultati:
1-21
|